The decreased DNMT1 and HDAC2 enrichments in ESCC cells after PAR4-AP treatment provided a novel molecular mechanism for promoting p16 gene transcription in ESCC cells. This evidence concerns the gene F2RL3 and esophageal squamous cell carcinoma.